Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMA & BIOTECH
INDUSTRY : MAJOR PHARMACEUTICALS
GENMAB - ADR
Genmab - ADR
XNAS: GMAB
Await Turnaround
Download real time
26.22
0.36
(
1.39
%)
25.99% Fall from 52W High
399.4K
XNAS Volume
XNAS
25 Jun, 2026 10:36 AM (EDT)
Watchlist
Portfolio
Alert
My Notes
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
Technicals
Price History/Seasonality
Ownership
Politician Trades
Insider Deals
Corporate Actions
All
Dividend
Split
Board Meetings
About
Genmab (ADR) - GMAB - stock price prediction, stock price target, analyst ratings from 11 analysts
Genmab (ADR) has a share price target of US$ 37, revenue growth forecast of 14.7%, and profit growth estimate of -23.9% for FY26, based on top 11 analyst calls.
Forecaster Screeners